Percutaneous Repair of Paravalvular Leaks After TAVR: The Challenge of Identifying Eligible Subjects

Courtesy of Dr. Carlos Fava.

Percutaneous Repair of Paravalvular Leaks After TAVRThis study enrolled 72 patients who underwent transcatheter aortic valve replacement with an Edwards Sapiens valve, and then experienced a leak of at least moderate severity.

 

Fifteen of them underwent a percutaneous leak repair after identification of the leak mostly through the presence of symptoms.

 

Both groups were similar. Patients who underwent percutaneous repair were younger. Plugs were used in the repair, and no patient experienced hemolytic anemia.

 

The procedure was successful in 13 patients. In 2 of them, crossing of the leak was impossible to achieve. One patient who continued experiencing symptoms required a new intervention.

 

At 20 months of follow-up, there was 1 (13.8%) death in the group of patients who underwent a leak repair and 24 (42%) deaths in the control group. Leak repairs benefited patients, who experienced improvement in symptom status, reduction in subsequent hospitalizations, and reduction in B-type natriuretic peptide levels.

 

Conclusion

Transcatheter repair of paravalvular leaks after TAVR can be safe and effective in a selected patient group and may lead to reductions in hospitalizations, and improvement in symptoms and long-term survival.

 

Editorial Comment

Paravalvular leaks with current technology occur in 13%-15% of cases and are one of the technological challenges to be worked out in the future.

 

In these cases, identifying patients eligible for this procedure is of the utmost importance, since leaks can be repaired safely and effectively, improving quality of life and long-term survival.

 

Courtesy of Dr. Carlos Fava. Buenos Aires Favaloro Foundation, Argentina.

 

Title: Outcome of Paravalvular Leak Repair After Transcatheter Aortic Valve Replacement with a Balloon-Expandable Prothesis.

 Reference: Abhijeet Dhoble, et al. Catheterization and Cardiovascular Interventions 2017;89:462-468.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

Can TAVI Be Safely Performed in Patients With Bicuspid Aortic Valve?

Bicuspid aortic valve (BAV) represents an anatomical challenge for transcatheter aortic valve replacement (TAVR) due to the frequent presence of elliptical annuli, fibroc calcific...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...